Les Kaplan

Director/Board Member at NICOX SA

73 year

Health Technology

Consumer Services

Finance

Active connections

Name	Gender	Age	Linked companies	Collaboration
Michele Garufi	M	70	NICOX SA Nicox Ophthalmics, Inc. Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.	28 years
Stephen Davis	M	63	ACADIA PHARMACEUTICALS INC.	10 years
Diane Tang-Liu	M	-	Aiviva Biopharma, Inc. Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then.	9 years
Lauren Silvernail	F	65	NICOX SA ALLERGAN, INC. Nicox Ophthalmics, Inc. Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.	16 years
Jean-François Labbé	M	73	NICOX SA Nicox Ophthalmics, Inc. Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.	14 years
Gavin M. Spencer	M	53	NICOX SA	19 years
Luzi Andreas von Bidder	M	71	NICOX SA Nicox Ophthalmics, Inc. Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.	10 years
Stephen Biggar	M	53	ACADIA PHARMACEUTICALS INC.	11 years
Adrienne Graves	M	69	NICOX SA Nicox Ophthalmics, Inc. Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX.	10 years
Daniel Bradbury	M	62	Keck Graduate Institute of Applied Life Sciences	18 years
Bob Mischler	M	-	ACADIA PHARMACEUTICALS INC.	9 years
Laura Brege	F	66	ACADIA PHARMACEUTICALS INC.	16 years
Don Soland	M	65	ACADIA PHARMACEUTICALS INC.	9 years
Emmanuelle Pierry	F	-	NICOX SA	22 years
Stephen Eck	M	69	Keck Graduate Institute of Applied Life Sciences	-
Jamie Dananberg	M	66	Keck Graduate Institute of Applied Life Sciences	-
Paul Manning	M	68	Foundation Fighting Blindness Clinical Research Institute Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD.	-
Doug Hubatsch	M	-	NICOX SA	3 years
Sandrine Gestin	F	56	NICOX SA	25 years
Sheldon M. Schuster	M	-	Keck Graduate Institute of Applied Life Sciences	-
Rob Ackles	M	-	ACADIA PHARMACEUTICALS INC.	10 years
Bonnie Anderson	F	66	Keck Graduate Institute of Applied Life Sciences	-
George Golumbeski	M	67	Keck Graduate Institute of Applied Life Sciences	11 years
Karen Bernstein	M	71	Keck Graduate Institute of Applied Life Sciences	15 years
Vincent R. Anicetti	M	69	Keck Graduate Institute of Applied Life Sciences	13 years
Barbara Kosacz	F	66	Keck Graduate Institute of Applied Life Sciences	-
Rodney Markin	M	67	Keck Graduate Institute of Applied Life Sciences	9 years
Dennis Fenton	M	72	Keck Graduate Institute of Applied Life Sciences	-
Clifford A. Miller	M	-	Keck Graduate Institute of Applied Life Sciences	-
Larry Gold	M	82	Keck Graduate Institute of Applied Life Sciences	-
Alice T. Kane	F	76	Keck Graduate Institute of Applied Life Sciences	-
Catherine Burzik	F	73	Keck Graduate Institute of Applied Life Sciences	-
Yiu Nam Lau	M	63	Aiviva Biopharma, Inc. Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then.	-
Jinn Wu	M	75	Aiviva Biopharma, Inc. Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then.	8 years
Billy Tauzin	M	81	Keck Graduate Institute of Applied Life Sciences	-
Kiran Mazumdar-Shaw	F	71	Keck Graduate Institute of Applied Life Sciences	-
Mark Stevenson	M	61	Keck Graduate Institute of Applied Life Sciences	-
Jay Flatley	M	71	Keck Graduate Institute of Applied Life Sciences	-
Bob E. Curry	M	77	Keck Graduate Institute of Applied Life Sciences	-
Chung Chiang Hsu	M	75	Aiviva Biopharma, Inc. Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then.	-
Michael Smith	M	79	Keck Graduate Institute of Applied Life Sciences	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Douglas Ingram	M	61	ALLERGAN, INC.	19 years
Thomas H. Aasen	M	63	ACADIA PHARMACEUTICALS INC.	16 years
James Hindman	M	63	ALLERGAN, INC.	31 years
Jeffrey Edwards	M	64	ALLERGAN, INC.	22 years
Uli Alf Hacksell	M	74	ACADIA PHARMACEUTICALS INC.	15 years
Mark R. Brann	M	-	ACADIA PHARMACEUTICALS INC.	13 years
Herb Boyer	M	87	ALLERGAN, INC.	19 years
David Pyott	M	70	ALLERGAN, INC.	17 years
Stephen J. Ryan	M	83	ALLERGAN, INC.	11 years
Aimee Weisner	F	55	ALLERGAN, INC.	4 years
Eric Brandt	M	62	ALLERGAN, INC.	6 years
Lotte Sønderbjerg	F	62	ACADIA PHARMACEUTICALS INC.	7 years
Glenn F. Baity	M	54	ACADIA PHARMACEUTICALS INC.	14 years
Leslie L. Iversen	M	86	ACADIA PHARMACEUTICALS INC.	18 years
Torsten Erik Rasmussen	M	78	ACADIA PHARMACEUTICALS INC.	17 years
William Humphries	M	57	ALLERGAN, INC.	8 years
Michael T. Borer	M	65	ACADIA PHARMACEUTICALS INC.	11 years
Birgit Stattin Norinder	F	75	NICOX SA	7 years
William McDowall Wells	M	63	ACADIA PHARMACEUTICALS INC.	4 years
Russ Ray	M	77	ALLERGAN, INC.	12 years
J. Michael Judy	M	-	ALLERGAN, INC.	8 years
James A. Nash	M	73	ACADIA PHARMACEUTICALS INC.	-
Louis T. Rosso	M	-	ALLERGAN, INC.	16 years
Leonard Schaeffer	M	78	ALLERGAN, INC.	18 years
Mary Gray	M	71	ACADIA PHARMACEUTICALS INC.	11 years
Michael R. Gallagher	M	77	ALLERGAN, INC.	-
Roy J. Wilson	M	68	ALLERGAN, INC.	-
Philippe Masquida	M	62	NICOX SA	4 years
Leonard R. Borrmann	M	66	ACADIA PHARMACEUTICALS INC. ALLERGAN, INC.	16 years
Abhay Joshi	M	61	ALLERGAN, INC.	5 years
Srdjan Stankovic	M	67	ACADIA PHARMACEUTICALS INC.	7 years
Caroline F. van Hove	F	43	ALLERGAN, INC.	16 years
Tsutomu Okimura	M	-	ALLERGAN, INC.	-
Frederick C. Beddingfield	M	59	ALLERGAN, INC.	-
Janice Drew	F	-	ALLERGAN, INC.	-
Robert T. Joseph	M	47	ALLERGAN, INC.	2 years
David Endicott	M	58	ALLERGAN, INC.	27 years
Julian Gangolli	M	66	ALLERGAN, INC.	17 years
Rosh Chandraratna	M	75	ALLERGAN, INC.	20 years
David F. Power	M	-	ALLERGAN, INC.	18 years
Niv Edward Caviar	M	56	ALLERGAN, INC.	5 years
F. Ball	M	68	ALLERGAN, INC.	16 years
Roger G. Mills	M	67	ACADIA PHARMACEUTICALS INC.	9 years
A. Bender	M	84	ALLERGAN, INC.	25 years
James F. Barlow	M	65	ALLERGAN, INC.	13 years
Don A. Kennard	M	77	ALLERGAN, INC.	10 years
Scott Michael Whitcup	M	64	ALLERGAN, INC.	15 years
Matthias C. Kurth	M	68	ALLERGAN, INC.	-
John Kaiser	M	68	ACADIA PHARMACEUTICALS INC.	1 years
Karen Osar	F	74	ALLERGAN, INC.	7 years
C. Trenary	M	66	ALLERGAN, INC.	8 years
Daniel P. Cafaro	M	67	ALLERGAN, INC.	15 years
Handel E. Evans	M	-	ALLERGAN, INC.	18 years
Vicente J. Anido	M	71	ALLERGAN, INC.	3 years
Thomas A. Mitro	M	66	ALLERGAN, INC.	22 years
Edward P. Monaghan	M	-	ALLERGAN, INC.	-
J. Engle	M	74	ALLERGAN, INC.	15 years
Steven R. Carlson	M	67	ALLERGAN, INC.	8 years
Catherine Turkel	M	63	ALLERGAN, INC.	17 years

Statistics

Country	Connections	% of total
United States	94	94.00%
France	11	11.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections